Profil
Mr. James D.
Mckean is Research Analyst at Atlantic Equities LLP.
He covered the pharmaceutical and healthcare sector since 1991, including 12 years in equity research with Morgan Stanley.
He also worked in the pharmaceutical industry with Ciba-Geigy (now Novartis).
He holds a BSc from Glasgow University and gained an MBA from Strathclyde Business School in 1988.
Ehemalige bekannte Positionen von James D. McKean
| Unternehmen | Position | Ende |
|---|---|---|
AE Continuation LLP
 AE Continuation LLP Investment Banks/BrokersFinance AE Continuation LLP is a US equity brokerage firm headquartered in London, UK. Formerly known as Hispaniola LLP and as Atlantic Equities LLP, the firm was founded in 2003 by Christopher Middleton, Hamilton Faber, Keely Oliver, Marlus McNally and Vernon Golding. They were acquired by Redburn (Europe) Ltd. in 2023 and change their name to AE Continuation LLP. | Analyst-Equity | 27.04.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
AE Continuation LLP
AE Continuation LLP Investment Banks/BrokersFinance AE Continuation LLP is a US equity brokerage firm headquartered in London, UK. Formerly known as Hispaniola LLP and as Atlantic Equities LLP, the firm was founded in 2003 by Christopher Middleton, Hamilton Faber, Keely Oliver, Marlus McNally and Vernon Golding. They were acquired by Redburn (Europe) Ltd. in 2023 and change their name to AE Continuation LLP. | Finance |
